Skip to content

Author

Mahjabeen Rashid

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Dec 2026

Inclisiran: A Novel Agent in the Management of Hypercholesterolemia

PCSK9 is a serine protease that binds to the LDL receptors and targets the receptors for lysosomal degradation, thus reducing their recycling and decreasing the removal rate of circulating LDL-C. Monoclonal antibodies directed against PCSK9, such alirocumab and evolocumab, have been shown to cause a significant reducti...

L. Alam, Ali O. Aldamen, Namhee Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.